Canon acquires Swiss MRI R&D company

Canon Medical Systems has concluded a contract to acquire all shares of Skope Magnetic Resonance Technologies AG, headquartered in Zurich, Switzerland. With a unique research and development team, Skope is a company devoted to providing MRI users with unprecedented imaging quality and performance. Skope’s expertise in MRI sensorics, signal-processing and image reconstruction covers the entire chain from signal acquisition to image generation. As a result, reproducible image quality, great image detail and time-saving MRI scanning can be achieved. Skope is equipping leading MRI research sites with its high-precision magnetic field monitoring systems and sophisticated image reconstruction software to facilitate next-generation MR imaging and diagnostics.

Canon Medical Systems succeeded in developing and introducing the first Japanese MRI in1983, and has been devoting itself to research and development of innovative MRI technologies such as Pianissimo, Canon Medical’s unique acoustic noise reduction technology, which provides  extraordinary patient comfort.

Canon Medical Systems said that it will leverage Skope’s  talent to promote advanced research and development of MRI systems, committing to innovative MRI solutions for uncompromised patient care.

Canon offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MR, as well as a full suite of Healthcare IT solutions, across the globe. The company’s  goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.